CrossrefInfokarte
Evaluation of Receptor Activator of Nuclear Factor Kappa-B Ligand and Osteoprotegerin Levels in Patients with Type 2 Diabetes Mellitus Treated with Oral Anti-diabetics (Sulfonylurea and Metformin) or Insulin: Bone Tissue Perspective
Istanbul Medical Journal · 2019
DOI: 10.4274/imj.galenos.2018.04657 ↗Abstract
Kein Abstract verfügbar.
EUVIMED